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Purpose: The goal of this study is to determine whether increased optic atrophy type 1 (OPA1) expression protects against
retinal ganglion cell (RGC) death in glaucomatous DBA/2J mice.
Methods: Intraocular pressure in DBA/2J mice was measured, and pre-glaucomatous DBA/2J mice eyes were transfected
with recombinant adeno-associated virus serotype 2 (AAV2) constructs including AAV2-wild type (WT) mOPA1 for two
months. Increased OPA1 expression was confirmed by western blotting and RGC survival was assessed by retrograde
labeling with FluoroGold. In addition, apoptotic cell death and mitochondrial structure were determined in AAV2-WT
mOPA1-transfected differentiated RGC-5 cells exposed to elevated hydrostatic pressure (30 mmHg) for three days.
Results: WT AAV2-mOPA1 transfection significantly increased 90 kDa and 80 kDa OPA1 isoforms in the retina of
glaucomatous DBA/2J mice. OPA1 immunoreactivity was increased in the inner nuclear layer, inner plexiform layer, and
ganglion cell layer in nine month-old glaucomatous DBA/2J mice transfected with AAV2-WT mOPA1. Overexpression
of OPA1 significantly increased RGC survival at two months after AAV2-WT mOPA1 transfection, and decreased
activation of both astroglia and microglia in the retina of glaucomatous DBA/2J mice. Also, overexpression of OPA1 in
differentiated RGC-5 cells resulted in less apoptotic cell death and blocked mitochondrial fission following elevated
hydrostatic pressure.
Conclusions: OPA1 can directly modulate RGC survival, and increasing OPA1 expression may protect against RGC
death in glaucomatous optic neuropathy.
Elevated intraocular pressure (IOP) is an important risk
factor for optic nerve head damage and retinal ganglion cell
(RGC)  death  in  glaucoma  [1].  However,  the  precise
pathophysiological  relationship  between  elevated  IOP  and
RGC  death  remains  poorly  understood.  Mitochondrial
fission-mediated mitochondrial dysfunction has been linked
to  neuronal  cell  death  in  both  acute  and  chronic
neurodegenerative  disorders  [2-6].  Further,  it  has  been
hypothesized that alterations of optic atrophy type 1 (OPA1),
a mitochondrial fusion protein, contribute to RGC death in
glaucoma  [2,3].  However,  the  direct  relationships  among
elevated  IOP,  OPA1  expression,  and  mitochondrial
dysfunction-mediated  RGC  death  in  glaucoma  remain
unknown.
Mitochondria  are  autonomous  and  morphologically
dynamic organelles that structurally reflect a precise balance
of ongoing fission and fusion within a healthy cell [4-8]. This
balance is regulated by a family of dynamin-related GTPases
that exert opposing effects. OPA1—the human ortholog of
Mgm1p/Msp1p—and  mitofusins  are  required  for
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mitochondria fusion. In contrast, dynamin-related protein1
promotes mitochondrial fission [5,9]. Mutations in OPA1,
which  is  involved  in  various  processes  related  to
mitochondrial  inner  membrane  structural  dynamics,  are
linked with neurodegenerative disease in humans and cause
autosomal  dominant  optic  atrophy,  a  common  form  of
hereditary optic neuropathy [10,11].
OPA1 is expressed in the soma and axons of the RGCs
as well as in the horizontal cells [12-15]. Emerging evidence
suggests that downregulation of OPA1 causes mitochondrial
fission leading to cytochrome c release and apoptosis in HeLa
cells, as well as induces aggregation of the mitochondrial
network  in  purified  RGCs  [16-19].  In  contrast,  increased
OPA1 expression protects cells from apoptosis by preventing
cytochrome  c  release  and  by  stabilizing  the  shape  of
mitochondrial cristae [20,21]. Together, these results suggest
that  the  direct  modulation  of  OPA1  could  regulate  RGC
survival.
Hence, the present study was undertaken to determine
whether increasing OPA1 expression protects against RGC
death  in  glaucomatous  DBA/2J  mice  or  in  differentiated
RGC-5 cells exposed to elevated hydrostatic pressure.
METHODS
Plasmid and recombinant adeno-associated virus serotype 2
constructs: The wild type (WT) mOPA1 plasmid [22] was
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1331provided  by  Drs.  Takumi  Misaka  (University  of  Tokyo,
Japan) and Yoshihiro Kubo (National Institute for Physiologic
Sciences, Japan). It is used to produce recombinant adeno-
associated virus serotype 2 (AAV2)-WT mOPA1 (4.1×1011
GC/ml) using the pAAV-CMV-shuttle by Applied Viromics
(Fremont,  CA).  AAV2-CMV-GFP  (1×1012  GC/ml)  and
AAV2 Null (1×1012 GC/ml) were purchased from Applied
Viromics. AAV2 Null that does not contain any gene insert is
made using pAAV-CMV-shuttle.
Animals:  All  procedures  concerning  animals  were  in
accordance with the ARVO Statement for the Use of Animals
in  Ophthalmic  Vision  Research  and  under  the  protocols
approved  by  institutional  IACUC  committees  at  the
University of California-San Diego. Adult female DBA/2J
(The Jackson Laboratory, Bar Harbor, ME) and C57BL/6
(Harlan Laboratories, Indianapolis, IN) mice were housed in
covered cages, fed with a standard rodent diet ad libitum, and
kept on a12 h:12 h light-dark cycle. Prior studies have shown
that IOP and optic nerves appear to be normal in three-month-
old  DBA/2J  mice  [23-26].  IOP  elevation  onset  typically
occurs between five and seven months of age, and by nine
months of age, IOP-associated optic nerve axon loss is well
advanced [23-27].
IOP  measurement:  IOP  measurement  was  performed  as
described previously [2,23,28]. Starting at six month of age,
IOP was measured monthly. Inclusion criteria for this study
was IOP less than 20 mmHg at six months of age and IOP
greater than 20 mmHg at nine months of age (n=50 mice).
Briefly, mice were anesthetized with a mixture of ketamine
(100 mg/kg, Ketaset; Fort Dodge Animal Health, Fort Dodge,
IA) and xylazine (9 mg/kg, TranquiVed; Vedeco, Inc., St.
Joseph, MO), and then pressure was measured by the insertion
of  a  sterilized,  water-filled  microneedle  with  an  external
diameter of 50 to 70 μm connected to a pressure transducer
into the anterior chamber.
Intravitreal injection of adeno-associated virus serotype 2
constructs: The seven-month-old DBA/2J and C57BL/6 mice
were anesthetized with a mixture of ketamine and xylazine,
and with topical 1% proparacaine eye drops. To facilitate the
injection, a hole was made in the sclera 3 mm posterior to the
superotemporal limbus. A Hamilton syringe with 34-gauge
needle (Hamilton Co., Reno, NV) was used to inject 5 µl of
AAV2 Null, AAV2-CMV-GFP, or AAV2-WT mOPA1 into
the vitreous humor. Injections were given slowly over 1 min
and the needle was maintained in position for an additional 10
min to minimize vector loss through the injection tract. At nine
months of age, the mice were killed by an intraperitoneal (IP)
injection  of  a  mixture  ketamine  and  xylazine,  and  retinal
tissues were prepared as below.
Retrograde  labeling  of  retinal  ganglion  cells:  One  week
before  sacrifice,  retrograde  tracers  were  microinjected
bilaterally into the superior colliculi of mice anesthetized with
a mixture of ketamine and xylazine in a stereotactic apparatus,
as  previously  described  [14].  1,1’-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiI; 1 µl/injection
of 5%; diluted in 100% ethanol; Molecular Probes) was used
for double labeling with AAV2-CMV-GFP, or FluoroGold
(1 µl/injection of 4%; diluted in saline; Fluorochrome Inc.,
Englewood, CO) was used for RGC counting. RGC counting
was done by two investigators in a masked fashion and the
scores were averaged.
Tissue  preparations:  The  mice  were  anesthetized  with
isoflurane  and  killed  by  an  IP  injection  of  a  mixture  of
ketamine  and  xylazine.  For  immunohistochemistry,  the
retinas were dissected from the choroid and fixed with 4%
paraformaldehyde in phosphate buffered saline (PBS, pH 7.4)
for 2 h at 4 °C. After several washes in PBS, retinas were
dehydrated through graded ethanols and then embedded in a
polyester wax as described previously [14]. For the western
blot analyses, whole retinas were immediately used.
Western blot analysis: Retinas were dissected from the sclera
and then immediately homogenized in a glass-Teflon Potter
homogenizer in a lysis buffer (20 mM Hepes, pH 7.5/10 mM
KCl/1.5 mM MgCl2/1 mM EDTA/1 mM EGTA/1 mM DTT/
0.5%  CHAPS/complete  protease  inhibitors;  Roche
Biochemicals, Indianapolis, IN). Ten micrograms of pooled
retinas (n=4 retinas/group) from each group were separated
by PAGE and electro-transferred to PVDF membranes. The
membrane  was  blocked  with  5%  nonfat  dry  milk/0.05%
Tween-20/PBS;  incubated  with  mouse  monoclonal  anti-
OPA1  antibody  (H-300,  1:1,000;  BD  Transduction
Laboratories, San Diego, CA), mouse monoclonal anti-glial
fibrillary acidic protein antibody (GFAP, 1:3000; Sigma, St.
Louis,  MO),  or  mouse  monoclonal  anti-actin  antibody
(1:2,000; Chemicon-Millipore, Billerica, MA); rinsed with
0.05% Tween-20/PBS; incubated with peroxidase-conjugated
goat antimouse IgG (1:2,000; Bio-Rad, Hercules, CA); and
developed using chemiluminescence detection (ECL Plus, GE
Healthcare  Bio-Sciences,  Piscataway,  NJ).  Images  were
analyzed with a digital fluorescence imager (Storm 860; GE
Healthcare Bio-Sciences) and band densities were normalized
using  actin  as  the  calibrator  with  ImageQuant  TL  (GE
Healthcare Bio-Sciences).
Immunohistochemical  analyses:  Immunohistochemical
staining of 7-µm retinal sections or wholemounts was done
by the immunofluorescent method. Primary antibodies were
mouse  monoclonal  anti-neurofilament  (1:100;  Sigma)  to
identify axons, mouse monoclonal anti-GFAP (1:300; Sigma)
to identify astrocytes, rabbit polyclonal anti-Iba 1 (1:100;
Wako Chemicals, Osaka, Japan) to identify microglial cells,
and rabbit polyclonal anti-mOPA1 (1:500, a gift from Takumi
Misaka, University of Tokyo, and Yoshihiro Kubo, National
Institute for Physiologic Sciences, Japan) [22]. To prevent a
non-specific  background,  tissues  were  incubated  with  3%
normal donkey serum/PBS for 1 h at room temperature and
then with the primary antibodies for 24 or 72 h at 4 °C. After
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secondary antibodies, Alexa Fluor 488 dye-conjugated goat
antimouse  IgG  (1:100;  Invitrogen,  Carlsbad,  CA),  Alexa
Fluor  488  dye-conjugated  goat  antirabbit  IgG  (1:100;
Invitrogen),  or  Alexa  Fluor  569  dye-conjugated  goat
antirabbit IgG (1:100; Invitrogen), for 4 or 24 h at 4 °C and
then washed with PBS. The sections were counterstained with
the nucleic acid stain Hoechst 33342 (1 µg/ml, Invitrogen) in
PBS.  Images  were  acquired  with  confocal  microscopy
(Olympus FluoView1000; Olympus, Tokyo, Japan). Image
exposures were the same for all tissue sections and were stored
on a computer (Photoshop files; Adobe Systems Inc., San
Jose, CA).
Retinal ganglion cell-5 cell studies: RGC-5 cells were grown
on 12 mm coverslips in 24 well plates as previously described
[3,29-32]  and  cotransfected  by  exposure  to  a  medium
containing  AAV2  Null  (1×1012  GC/ml)  or  AAV2-WT
mOPA1 (4.1×1011 GC/ml). Differentiation of RGC-5 cells
was  induced  three  days  after  treatment  with  succinyl
concanavalin  A  (50  µg/ml,  Sigma,  St.  Louis,  MO).  A
Figure 1. Intraocular pressure (IOP) measurement in nine-month-old
glaucomatous  DBA/2J  mice  following  transfection  with  adeno-
associated  virus  serotype  2-cytomegalovirus-green  fluorescent
protein (AAV2-CMV-GFP) or adeno-associated virus serotype 2-
wild type (AAV2-WT) optic atrophy type 1 (mOPA1). A: Similar
mean IOP was observed in the eyes of nine-month-old DBA/2J mice
injected  with  either  AAV2-CMV-GFP  (n=19)  or  AAV2-WT
mOPA1 (n=29). B: Distribution of IOP in the eyes of mice nine
months of age following injection of vectors. Data represent the mean
±SD. There was no significant IOP difference.
pressurized incubator was used to expose the cells to elevated
hydrostatic  pressure  as  previously  described  [3,30].  To
determine mitochondrial morphology and cell death, nuclei
were stained with Hoechst 33342 (1 μg/ml; Molecular Probes;
10  min  at  room  temperature)  and  visualized  using
fluorescence microscopy. Each evaluated cell was scored as
having normal or pyknotic (apoptotic) nuclei in several fields.
At  least  200  cells  were  scored  for  each  experimental
condition. Results were expressed as a percentage of cells with
apoptotic nuclei among the total cells that were counted by
two investigators in a masked fashion. Mitochondria were
labeled by the addition of red fluorescent mitochondrial dye
to the cultures (100 nM final concentration; MitoTracker Red
CMXRos; Invitrogen) as described previously [14].
Statistical analysis: The data were presented as the mean±SD.
Comparisons of two or three experimental conditions were
evaluated using the paired or unpaired Student t test, or one-
way ANOVA and Bonferroni t test. p<0.05 was considered to
be statistically significant.
RESULTS
Effect of increased optic atrophy type 1 expression on retinal
ganglion cell survival: Mean IOP was 19.6±2.9 mmHg in the
eyes  of  the  nine-month-old  DBA/2J  mice  injected  with
AAV2-CMV-GFP (n=19) and 20.1±4.0 mmHg in the eyes of
the nine-month-old DBA/2J mice injected with AAV2-WT
mOPA1  (n=29;  Figure  1).  These  were  no  significant
differences  in  IOP  between  the  AAV2-CMV-GFP  and
AAV2-WT mOPA1-injected glaucomatous DBA/2J mice at
nine months of age.
To  evaluate  the  targeting  of  recombinant  AAV2
constructs, the intravitreal injection of AAV2-CMV-GFP was
combined with retrograde labeling of RGCs by a DiI injection
into the superior colliculi. Following the AAV2-CMV-GFP
injection  in  the  seven  month-old  DBA/2J  mice,  GFP
expression was observed throughout the whole retina and
optic nerve in the DBA/2J mice at nine months of age (Figure
2A-F). Double labeling with DiI showed the entire dendritic
tree of a subset of RGCs labeled with GFP (Figure 2D).
Specifically, GFP was filled in the RGC somas and their axons
in the ganglion cell layer (GCL) and nerve fiber layer (Figure
2E), and in the optic nerve head (Figure 2F).
The OPA1 antibody recognized two major isoforms of
the OPA1 protein (a 90-kDa [called the large or L isoform]
and an 80-kDa [called small or S isoform]) in the total retinal
protein extracts of the nine-month-old glaucomatous DBA/2J
mice transfected with AAV2-CMV-GFP. In contrast, both the
L and S isoforms of the OPA1 protein were significantly
increased in the nine-month-old glaucomatous DBA/2J mice
transfected  with  AAV2-WT  mOPA1  (n=4  retinas/group,
p<0.05, Figure 3A,B). Further, OPA1 immunoreactivity was
increased in the inner nuclear layer, inner plexiform layer, and
ganglion cell layer in the nine-month-old glaucomatous DBA/
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1333Figure 2. Adeno-associated virus serotype 2-cytomegalovirus-green fluorescent protein (AAV2-CMV-GFP) labeling in the retina and optic
nerve of six-month-old DBA/2J mice. A: Normal appearance of retinal cross section. B: The ganglion cell layer (GCL) from the retinal
flatmount. C: Optic nerve fiber staining in a whole eye section after triple labeling with AAV2-CMV-GFP (green), neurofilament (red), and
glial fibrillary acidic protein (GFAP; blue). D: The entire dendritic tree (arrowheads) and cell body (arrow) of retinal ganglion cell (RGC)
labeled with AAV2-CMV-GFP (green) and DiI (red). E: Enlargement of the retinal section shown in panel C to illustrate staining in the RGC
somas (arrows) and axons (arrowheads) in the GCL. F: Enlargement of the optic nerve head shown in panel C demonstrates triple labeling
with AAV2-CMV-GFP (green), neurofilament (red), and GFAP (blue). Abbreviations: IPL represents inner plexiform layer; GCL represents
ganglion cell layer; CA represents central artery. Scale bar indicates 20 µm (A, D-F), 50 µm (B), and 100 µm (C).
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13342J mice transfected with AAV2-WT mOPA1 compared with
the nine-month-old glaucomatous DBA/2J mice transfected
with AAV2 Null (Figure 3C). In comparison with the nine-
month-old non-glaucomatous C57BL/6 mice transfected with
AAV2-CMV-GFP (n=4 retinas, Figure 4A, Table 1), the nine-
month-old  glaucomatous  DBA/2J  mice  transfected  with
AAV2-CMV-GFP had 38% less RGCs in the central, middle,
and peripheral retinas combined (n=5 retinas, Figure 4B,D,
Table 1; p<0.05). The nine-month-old glaucomatous DBA/2J
mice  transfected  with  AAV2-WT  mOPA1  had  13%  less
RGCs than the nine-month-old non-glaucomatous C57BL/6
mice transfected with AAV2-CMV-GFP (n=7 retinas, Figure
4C,D, Table 1; p<0.05).
Effect of increased optic atrophy type 1 expression on retinal
astroglial and microglial activation: In comparison with the
nine-month-old glaucomatous DBA/2J mice transfected with
AAV2 Null, GFAP expression was significantly decreased in
the nine-month-old glaucomatous DBA/2J mice transfected
with AAV2-WT mOPA1 (Figure 5A,B; p<0.05). In parallel,
AAV2 Null transfection increased GFAP-positive astroglial
activation in the GCL of the nine-month-old glaucomatous
DBA/2J mice (Figure 5C). It appeared that Iba 1-positive
microglial activation was stronger than astroglial activation in
the GCL of the nine-month-old glaucomatous DBA/2J mice
transfected with AAV2 Null (Figure 5D). However, the nine-
month-old  glaucomatous  DBA/2J  mice  transfected  with
AAV2-WT mOPA1 had less activation of both astroglia and
microglia in the retina (Figure 5F-H). In addition, retinas from
the nine-month-old glaucomatous DBA/2J mice transfected
with  AAV2  Null  showed  a  similar  activation  by
immunohistochemistry of both astroglia and microglia as the
untransfected  nine-month-old  glaucomatous  DBA/2J  mice
(data not shown).
Effect  of  increased  optic  atrophy  type  1  expression  on
pressurized retinal ganglion cell-5 cells: As in the protein
extracts from the retina, the OPA1 antibody recognized two
isoforms of the OPA1 protein (a 90-kDa [L] and an 80-kDa
[S]) in the total protein extracts from RGC-5 cells (Figure
6A,B).  There  was  no  significant  difference  in  OPA1
expression  between  the  AAV2  Null-transfected  non-
Figure 3. Retinal ganglion cell (RGC)
survival in glaucomatous DBA/2J mice
following  transfection  with  adeno-
associated  virus  serotype  2-
cytomegalovirus-green  fluorescent
protein (AAV2-CMV-GFP) or adeno-
associated  virus  serotype  2-wild  type
(AAV2-WT)  optic  atrophy  type  1
(mOPA1). A, B: The OPA1 antibody
recognized 90-kDa (L) and 80-kDa (S)
isoforms of OPA1 protein in the total
retinal protein extracts of glaucomatous
DBA/2J mice transfected with AAV2-
CMV-GFP.  Conversely,  AAV2-WT
mOPA1-trasfected glaucomatous mice
had significantly increased isoforms of
the  OPA1  protein  compared  with
glaucomatous  DBA/2J  mice  treated
with  AAV2-CMV-GFP  (n=4  retinas/
group).  Data  represent  the  mean±SD
*Significant at p<0.05 compared with
nine-month-old glaucomatous DBA/2J
mice transfected with AAV2 Null. C:
OPA1  immunoreactivity  in
glaucomatous DBA/2J mice transfected
with  AAV2  Null.  D:  OPA1
immunoreactivity  in  glaucomatous
DBA/2J mice transfected with AAV2-
CMV-WT  mOPA1.  Abbreviations:
ONL  represents  outer  nuclear  layer;
OPL represents outer nuclear layer; IPL
represents inner plexiform layer; GCL
represents  ganglion  cell  layer;  CA
represents  central  artery.  Scale  bar
indicates 20 µm (C, D).
Molecular Vision 2010; 16:1331-1342 <http://www.molvis.org/molvis/v16/a147> © 2010 Molecular Vision
1335pressurized control and pressurized RGC-5 cells. In contrast,
both  isoforms  of  the  OPA1  protein  were  significantly
increased in the pressurized RGC-5 cells transfected with
AAV2-WT mOPA1 (Figure 6A,B, p<0.05). Hoechst 33342
staining showed that non-pressurized control RGC-5 cells
transfected  with  AAV2  Null  contained  normal  appearing
nuclei  (Figure  6C).  In  contrast,  pressurized  RGC-5  cells
transfected with AAV2 Null showed a significant apoptotic
nuclei (Figure 6D). However, increased OPA1 expression by
transfection  of  AAV2-WT  mOPA1  resulted  in  almost
complete protection from apoptotic cell death in pressurized
RGC-5 cells (Figure 6E,F; p<0.05).
Mitochondria in the non-pressurized control RGC-5 cells
transfected with AAV2 Null showed a typical filamentous and
fused mitochondrial network at three days (Figure 7A-D).
Elevated hydrostatic pressure induced mitochondrial fission
—characterized  by  the  conversion  of  tubular  fused
mitochondria  into  isolated  small  organelles—in  the
Figure 4. Retinal ganglion cell (RGC)
survival  in  nine-month-old
glaucomatous DBA/2J mice following
transfection with adeno-associated virus
serotype  2-cytomegalovirus-green
fluorescent protein (AAV2-CMV-GFP)
or  adeno-associated  virus  serotype  2-
wild  type  (AAV2-WT)  optic  atrophy
type  1  (mOPA1).  The  representative
flatmount  photomicrographs  are  from
the middle retina following retrograde
labeling  with  FluoroGold.  A:  Non-
glaucomatous  C57BL/6  mice
transfected  with  AAV2-CMV-GFP;
n=4  retinal  flatmounts/mice/group.  B:
Glaucomatous  DBA/2J  mice
transfected  with  AAV2-CMV-GFP;
n=4 retinal flatmounts/mice/group. C:
Glaucomatous  DBA/2J  mice
transfected  with  AAV2-WT  mOPA1;
n=7 retinal flatmounts/mice/group. D:
The  quantitative  analysis  of  RGC
survival. Data represent the mean±SD
*Significant at p<0.05 compared with
non-glaucomatous  C57BL/6  mice
transfected with  AAV2-CMV-GFP  or
**Significant at p<0.05 compared with
glaucomatous DBA/2J mice transfected
with  AAV2-CMV-GFP.  Scale  bar
indicates 50 µm (C-E).
TABLE 1. EFFECTS OF INCREASED OPTIC ATROPHY TYPE 1 (OPA1) EXPRESSION ON THE CENTRAL, MIDDLE AND PERIPHERAL RETINAL GANGLION CELL
(RGC) SURVIVAL FROM 9-MONTH-OLD GLAUCOMATOUS DBA/2J MICE.
Strain Age (mo) Treatment
RGC density per retina (RGCs/mm2)
Central Middle Peripheral
C57BL/6 9 AAV2-CMV-GFP 5208±522 4389±555 3000±570
DBA/2J 9 AAV2-CMV-GFP 3539±370* 2922±367* 1585±160*
DBA/2J 9 AAV2-WT mOPA1 4260±712** 3820±470** 2775±450**
Values are given as means±SD. Comparison of three experimental conditions was evaluated using one-way ANOVA (ANOVA)
and  the Bonferroni  t-test. *Significant at p<0.05 compared with non-glaucomatous C57BL/6 mice transfected with adeno-
associated virus serotype 2-cytomegalovirus-green fluorescent protein (AAV2-CMV-GFP), n=4 retinal flatmounts/mice/group.
**Significant at p<0.05 compared with glaucomatous DBA/2J mice transfected with AAV2-CMV-GFP, n=7 retinal flatmounts/
mice/group.
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1336Figure 5. Increased optic atrophy type 1 (OPA1) expression inhibits activation of astroglia and microglia in the retinas of glaucomatous DBA/
2J mice. A, B: Adeno-associated virus serotype 2-wild type (AAV2-WT) mOPA1-trasfected glaucomatous mice significantly decreased GFAP
protein compared with glaucomatous DBA/2J mice treated with AAV2 Null. Relative intensity of chemiluminescence for each protein band
was normalized with actin used as the calibrator; n=4 retinas/group. Data represent the mean±SD *Significant at p<0.05 compared with
glaucomatous DBA/2J mice transfected with AAV2-CMV Null. C, D: Glaucomatous retina transfected with AAV2 Null exhibited significantly
induced activations of both astroglia (green, C) and microglia (red, D). E: Merged retina with triple labeling. F, G: Glaucomatous retina
transfected with AAV2-WT mOPA1 significantly reduced activation of both astroglia (green, F) and microglia (red, G). H: Merged retina
with triple labeling. The blue color shows FluroGold-labeled RGCs. Scale bar indicates 50 µm (C-H).
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1337pressurized RGC-5 cells transfected with AAV2 Null at 3 days
(Figure 7E,G). In contrast, increased OPA1 expression by
transfection of AAV2-WT mOPA1 blocked mitochondrial
fission in the pressurized RGC-5 cells (Figure 7F,H).
DISCUSSION
These results provide the first direct evidence that increased
OPA1 expression using an AAV2 vector system can increase
RGC survival in glaucomatous DBA/2J mice with elevated
IOP in vivo and in differentiated RGC-5 cells exposed to
elevated hydrostatic pressure in vitro. Moreover, increased
OPA1 expression significantly reduced the activation of both
astroglia and microglia in glaucomatous retina, and blocked
apoptotic  cell  death  in  RGC-5  cells  exposed  to  elevated
hydrostatic pressure. These findings suggest that increasing
OPA1 expression may protect RGCs against glaucomatous
damage.
Emerging  evidence  indicates  that  mitochondrial
structural and functional dynamics play an important role in
cell  and  animal  physiology.  Imbalance  in  the  control  of
mitochondrial fusion and fission dramatically alters overall
mitochondrial morphology [9]. Recent evidence suggests that
Figure 6. Increased optic atrophy type 1
(OPA1)  expression  blocks  apoptotic
cell  death  in  differentiated  retinal
ganglion cell (RGC)-5 cells exposed to
elevated  hydrostatic  pressure
(30 mmHg) for 3 days. A, B: The OPA1
antibody recognized 90-kDa (L) and 80-
kDa (S) isoforms of OPA1 protein in the
total protein extracts of non-pressurized
or  pressurized  cells  transfected  with
AAV2  Null  or  AAV2-WT  mOPA1.
Compared  with  pressurized  cells
transfected  with  AAV2  Null,
pressurized  cells  transfected  with
AAV2-WT  mOPA1  significantly
increased  both  isoforms  of  OPA1
protein  at  3  days.  Data  represent  the
mean±SD  *Significant  at  p<0.05
compared  with  pressurized  cells
transfected  with  AAV2  Null  (n=4
retinas/group).  C-E:  Non-pressurized
control  cells  transfected  with  AAV2
Null (C), pressurized cells transfected
with AAV2 Null (D), and pressurized
cells  transfected  with  AAV2-WT
mOPA1  (E).  The  cells  are
counterstained with Hoechst 33342. (F)
The quantitative analysis of apoptotic
cell  death  (n=200  cells  per  group,
arrows).  *Significant  at  p<0.05
compared with non-pressurized control
cells  transfected  with  AAV2  Null,
**Significant at p<0.05 compared with
pressurized  cells  transfected  with
AAV2 Null. Scale bar indicates 50 µm
(C-E).
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1338Figure 7. Increased optic atrophy type 1 (OPA1) expression blocks mitochondrial fission in differentiated retinal ganglion cell (RGC)-5 cells
exposed to elevated hydrostatic pressure (30 mmHg) for three days. Mitochondria are stained with MitoTracker Red. A, C: Non-pressurized
control cells without transfection. B, D: Non-pressurized control cells transfected with AAV2 Null. E,G: Pressurized cells transfected with
AAV2 Null. F,H: Pressurized cells transfected with AAV2-WT mOPA1. High magnification showed that increased OPA1 expression blocked
mitochondrial fission in pressurized cells that are counterstained with Hoechst 33342 (blue). Scale bar indicates 10 µm (A,C, F, H).
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1339excessive mitochondrial fission can lead to the breakdown of
the mitochondrial network, loss of mitochondrial DNA, and
respiratory defects in mammalian cells [33-35]. Intriguingly,
we recently reported that elevated IOP induces mitochondrial
fission, decreases OPA1 gene expression, triggers OPA1 and
cytochrome c release, and induces apoptotic cell death in the
retinas and optic nerves of glaucomatous DBA/2J mice [2,3].
Together  with  the  present  findings,  these  observations
indicate  that  reduced  OPA1  may  contribute  to  RGC
pathophysiology in glaucoma.
Gene  delivery  strategies  by  recombinant  AAV2
constructs have been explored as a method to prevent RGC
loss  in  experimental  animal  models  of  glaucoma  [36,37].
Because  we  previously  found  that  all  neurons  containing
OPA1 immunoreactivity were co-labeled with FluoroGold-
positive RGCs in a mouse model of glaucoma [14,38], we
developed a gene therapy strategy using the transfection of a
recombinant  AAV2-WT  mOPA1  construct  to  investigate
whether overexpression of OPA1 increases RGC survival in
glaucomatous DBA/2J mice with elevated IOP. Importantly,
our findings demonstrated the first evidence that increased
OPA1  expression  significantly  blocked  RGC  loss  in
glaucomatous DBA/2J mice. In comparison between non-
glaucomatous  C57BL/6  mice  and  OPA1-expressing
glaucomatous mice, we found no difference in RGC loss in
the peripheral retinas of these strains (p>0.05). In the central
and middle retina, however, RGC survival was 18.7% greater
in the non-glaucomatous C57BL/6 mice than in the OPA1-
expressing glaucomatous DBA/2J mice (p<0.05). As RGC
loss was much greater in the non-transfected glaucomatous
DBA/2J mice, these results indicated that our induction of
OPA1  provided  partial  protection  against  RGC  loss.  In
addition to protecting RGCs, it was confirmed that increased
OPA1 expression significantly reduced the activation of both
astroglia and microglia in glaucomatous retinas. Astroglial or
microglial activation coincides with RGC degeneration in
glaucomatous retinas in humans, rats, or mice [39-47]. Hence,
the present results suggest that increased OPA1 expression in
RGCs  may  indirectly  reduce  astroglial  or  microglial
activation  as  a  result  of  increased  RGC  survival.  AAV2
vectors introduced into the central nervous tissue generally
target neurons, but not other CNS cells such as astrocytes or
microglia [48]. However, the possibility that increased OPA1
expression  may  directly  contribute  to  the  deactivation  of
astroglia or microglia should be further explored.
Growing  evidence  demonstrates  that  increased  OPA1
expression  protects  cells  from  apoptosis  by  preventing
cytochrome  c  release  and  by  stabilizing  the  shape  of
mitochondrial cristae [20,21], while an OPA1 mutation or
deficiency contributes to mitochondrial fission and apoptotic
cell  death  in  many  cell  types  [16-18,49].  Further,
downregulation  of  OPA1  causes  aggregation  of  the
mitochondrial network in purified RGCs [19]. Recently, we
reported  that  elevated  hydrostatic  pressure  triggers
mitochondrial fission and OPA1 and cytochrome c release, as
well as induces apoptotic cell death and causes a significant
decrease of OPA1 gene expression in differentiated RGC-5
cells at three days [3]. In the present study, we observed that
increased OPA1 expression prevented mitochondrial fission.
Further,  it  significantly  blocked  apoptotic  cell  death  in
differentiated RGC-5 cells exposed to elevated hydrostatic
pressure for three days, supporting our notion that increased
OPA1  expression  could  block  mitochondrial  fission  and
subsequent  apoptotic  cell  death  in  glaucomatous  RGC
degeneration.  These  results  collectively  indicate  that
pressure-induced OPA1 alteration may directly contribute to
RGC death in glaucoma and that increased OPA1 expression
may protect against direct pressure damage to RGCs.
Because  most  of  pathogenic  mutations  in  OPA1  are
expected to produce a truncated non-functional OPA1 protein,
it  has  been  suggested  that  haploinsufficiency  is  a  major
pathomechanism  in  OPA1-associated  autosomal  dominant
optic atrophy [50,51]. Moreover, recent studies reported that
OPA1 mutant mice have a significantly lower (~50%) level
of retinal OPA1 protein, which is associated with increased
age-dependent loss of RGCs [52,53]. Consistent with these
results,  we  observed  that  nine-month-old  heterozygous
OPA1enu/+ mice have significantly lower OPA1 protein levels
and  greater  RGC  loss  than  corresponding  WT  littermate
control mice. Also, OPA1 immunoreactivity was decreased in
the GCL of heterozygous OPA1enu/+ mice compared with WT
littermate control mice (data not shown).
These results demonstrate a direct relationship between
OPA1 expression in RGCs and RGC survival, as well as
support the possibility that increased OPA1 expression may
promote  RGC  survival  in  glaucoma.  Thus,  direct
enhancement of OPA1 may provide a new strategy to protect
RGC death in various optic neuropathies including glaucoma.
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